Vanguard Global Advisers’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.6K Buy
+10,601
New +$28.6K ﹤0.01% 3270
2026
Q2
– Sell
-429
Closed -$472 – 3749
2026
Q1
$472 Buy
+429
New +$502 ﹤0.01% 3661

Other funds holding BOLD

Vanguard Global Advisers's BOLD Position: Q3 2026 in Review

Vanguard Global Advisers opened a new position in Boundless Bio (BOLD) in Q3 2026: 10,601 shares worth $26.6K. The stake represents ﹤0.01% of the portfolio and ranks #3270 among its holdings. This is a return to the name: Vanguard Global Advisers previously reported a position in BOLD as recently as Q1 2026.

Vanguard Global Advisers first reported a position in BOLD in Q1 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • Vanguard Global Advisers held 10,601 shares of Boundless Bio worth $26.6K as of Q3 2026.
  • Boundless Bio was a new Vanguard Global Advisers position in Q3 2026.
  • Boundless Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3270 holding.
  • Vanguard Global Advisers first reported a position in Boundless Bio in Q1 2026 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.